- Home
- OBIO vs CRGO Comparison
OBIO vs CRGO Comparison
Compare OBIO & CRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- CRGO
- Stock Information
- Founded
- OBIO 2017
- CRGO 2012
- Country
- OBIO United States
- CRGO Spain
- Employees
- OBIO N/A
- CRGO N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- CRGO Blank Checks
- Sector
- OBIO Health Care
- CRGO Finance
- Exchange
- OBIO Nasdaq
- CRGO Nasdaq
- Market Cap
- OBIO 124.9M
- CRGO 118.1M
- IPO Year
- OBIO N/A
- CRGO N/A
- Fundamental
- Price
- OBIO $3.01
- CRGO $2.12
- Analyst Decision
- OBIO Strong Buy
- CRGO Buy
- Analyst Count
- OBIO 5
- CRGO 1
- Target Price
- OBIO $14.20
- CRGO $3.50
- AVG Volume (30 Days)
- OBIO 236.8K
- CRGO 61.7K
- Earning Date
- OBIO 08-11-2025
- CRGO 08-18-2025
- Dividend Yield
- OBIO N/A
- CRGO N/A
- EPS Growth
- OBIO N/A
- CRGO N/A
- EPS
- OBIO N/A
- CRGO N/A
- Revenue
- OBIO $2,886,000.00
- CRGO $25,375,000.00
- Revenue This Year
- OBIO $20.47
- CRGO $26.97
- Revenue Next Year
- OBIO $11.45
- CRGO $26.11
- P/E Ratio
- OBIO N/A
- CRGO N/A
- Revenue Growth
- OBIO 30.23
- CRGO 21.92
- 52 Week Low
- OBIO $2.37
- CRGO $1.27
- 52 Week High
- OBIO $8.87
- CRGO $4.42
- Technical
- Relative Strength Index (RSI)
- OBIO 47.82
- CRGO 42.95
- Support Level
- OBIO $2.91
- CRGO $2.13
- Resistance Level
- OBIO $3.48
- CRGO $2.32
- Average True Range (ATR)
- OBIO 0.26
- CRGO 0.16
- MACD
- OBIO -0.01
- CRGO -0.02
- Stochastic Oscillator
- OBIO 28.78
- CRGO 9.30
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.